Multicenter, Double-Blind, Placebo-Controlled Crossover Study to Assess the Acute Prokinetic Efficacy of Nizatidine-Controlled Release (150 and 300mg) in Patients With Gastroesophageal Reflux Disease-Reference-Cited by-同舟云学术

Multicenter, Double-Blind, Placebo-Controlled Crossover Study to Assess the Acute Prokinetic Efficacy of Nizatidine-Controlled Release (150 and 300mg) in Patients With Gastroesophageal Reflux Disease

Published:2010-10 Issue:4 Volume:340 Page:259-263
ISSN:0002-9629
Container-title:The American Journal of the Medical Sciences
language:en
Short-container-title:The American Journal of the Medical Sciences

Author:

McCallum Richard W.,Sarosiek Irene,Hejazi Reza A.,Zarling Edwin J.,Goetsch Allen C.,Griffin Carl,Doyle Ralph T.,Rotenberg Keith

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. Ranitidine and nizatidine stimulate antral smooth muscle contractility via excitatory cholinergic mechanisms;Parkman;Dig Dis Sci,1998

2. Effect of gastric acid suppressants on human gastric motility;Parkman;Gut,1998

3. Gastric myoelectrical activity, gastric emptying and correlations with dyspepsia symptoms in patients with gastroesophageal reflux;Soykan;J Investig Med,1999

4. Gastric emptying in patients with gastroesophageal reflux;McCallum;Gastroenterology,1981

5. Prescribing information for Axid®;Reliant Pharmaceuticals,2000

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acid-Lowering Drugs for the Treatment of Gastro-esophageal Reflux Disease;Gastroesophageal Reflux in Children;2022

2. Gastrointestinal pharmacology: practical tips for the esophagologist;Annals of the New York Academy of Sciences;2020-08-21

3. Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression;BMC Medicine;2016-11-09

4. Emerging drugs for the treatment of gastroparesis;Expert Opinion on Emerging Drugs;2014-03-26

5. Nizatidine ameliorates gastroparesis in Parkinson's disease: A pilot study;Movement Disorders;2013-12-27